Pandemic Darling Moderna Needs a Reality Check
The Wall Street JournalModerna is spending aggressively to broaden the uses of its mRNA technology. Investors are losing patience.
Moderna is spending aggressively to broaden the uses of its mRNA technology. Investors are losing patience.